NCT00883064View on ClinicalTrials.gov

To Demonstrate the Relative Bioequivalence of Lisinopril 1 x 40 mg Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

March 31, 2000

Primary Completion Date

April 30, 2000

Study Completion Date

April 30, 2000

Conditions
Hypertension
Interventions
DRUG

Lisinopril 40 mg Tablet (EON Labs Manufacturing Inc, USA)

DRUG

Lisinopril 40 mg Tablet (Zestril) (Zeneca, USA)

Sponsors

Lead Sponsor

Sandoz
All Listed Sponsors
lead

Sandoz

INDUSTRY